Search fresh public links, source activity, and ready-to-use post angles for Translational Medicine.
Fresh curated links around Translational Medicine are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
New research coming out of the University of Toronto has shown that transfer RNA may offer a promising therapeutic avenue for treating genetic diseases.
It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable. The post Precision Medicine Transformed...
A preclinical study showed how chemically enhanced suppressor tRNAs combined with a lung-targeted delivery system can restore production of a critical protein in models of cystic f...
A contract manufacturer running multiple adeno-associated virus (AAV) programs says early engagement between key stakeholders, proactive risk assessments and platform knowledge is...
By EMANUEL SARKEES The United States is in the middle of what researchers are calling one of the most significant pharmacological developments in modern medicine. GLP-1 receptor ag...
The next era of medicine will not be defined by earlier detection alone, but by understanding dynamics. The post The Coming Shift from Biomarkers to Biological Trajectories appeare...
Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancersManagement to discu...
The CEO of Therorna discusses the science of behind circular RNA and why Western pharma hasn't paid enough attention to what's being built in China. The post Why Western pharma is...
A new study is bringing molecular precision to one of the most difficult problems in transplantation: understanding why a transplanted heart can appear similar under the microscope...
Through its entry into Lilly Gateway Labs, Rznomics officials say they plan to accelerate candidate discovery and development across its target gene database bank comprising over 2...
A team of veteran scientists from elite institutions has come together to form a new center dedicated to the crafting of personalized genetic medicines, adding to the growing list...
Among the first projects identified under the partnership is a Phase 2 extension study evaluating the safety and efficacy of IMN-003A cell therapy in adult and paediatric patients...
by Adrianne L. Jenner, Robyn P. Araujo, Noa L. Levi, Guy Ungerechts, Christine E. Engeland, Johannes P. W. Heidbuechel Immunotherapies have become a transformative therapeutic str...
An AI-based approach assesses disease severity in patients with myelodysplastic neoplasms (MDS), a form of blood cancer where one-third of patients progress to a more aggressive st...
Medicines Discovery Catapult provided its investment and expert support to help two biotech companies accelerate the development of new treatments for a range of autoimmune, inflam...
Many of the more sophisticated forms of medicine, including gene therapies and immunotherapies, are challenging to deliver to the brain. At the very least there are far fewer pract...
The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genom...
One of the transferred technologies is SHetA2, a drug candidate licensed to Emcure Pharmaceuticals for treating the precancerous cervical condition CIN
A new spatial transcriptomics framework compares tumor “floor plans." In a study of 262 solid tumors, the team identified recurring spatial groups that may connect spatial structur...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.